查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区结构心臟市场预测至 2028 年 - 区域分析 - 按产品、程序和最终用户
市场调查报告书
商品编码
1393997

亚太地区结构心臟市场预测至 2028 年 - 区域分析 - 按产品、程序和最终用户

Asia Pacific Structural Heart Market Forecast to 2028 - Regional Analysis - by Product, Procedure, and End User
出版日期: | 出版商: The Insight Partners | 英文 142 Pages | 订单完成后即时交付

价格

亚太心臟结构市场预计将从2022年的26.4967亿美元成长到2028年的43.7455亿美元。预计2022年至2028年CAGR为8.7%。

结构心臟器械领域的技术进步推动亚太结构心臟市场

与外科手术相比，经导管手术可以在更短的时间内改善患者的心臟状况。此外，微创手术降低了手术和心肺风险，从而提高了患者满意度。 TAVR因其能够为退化性主动脉瓣狭窄的治疗提供合理的选择而受到越来越多的关注。 2017年，Edwards Lifesciences的Edwards Sapien阀门正在PARTNER试验中进行研究。该瓣膜由牛心包组织瓣膜製成，并缝合在钴铬支架上。支架允许瓣膜最大程度地折迭，一旦扩张，就可以保持结构和径向支撑。此外，结构性心臟装置的最新发展重点关注左心耳（LAA）和卵圆孔未闭（PFO）封堵的适应症和结果，以预防心臟中风。提到了亚太心臟结构市场参与者的一些技术进步。 2023 年 2 月，美敦力宣布重新推出 Harmony 经导管肺动脉瓣 (TPV) 系统，这是一种微创替代心臟直视手术的方法，适用于患有天然或手术修復 RVOT 的先天性心臟病患者。 Evolut FX 在现有 Evolut 平台上添加了新功能，以增强医生的易用性和可预测的瓣膜部署。 2022年5月，飞利浦推出了EchoNavigator 4.0，这是其影像导引治疗解决方案的新版本，用于治疗结构性心臟病。 EchoNavigator 4.0 为飞利浦 EPIQ CVXi 介入性心臟病学超音波系统的使用者提供了对该公司影像引导治疗系统（称为「Azurion 平台」）上的即时融合成像的控制。 2021 年 9 月，雅培的 Epic Plus 和 Epic Plus Supra 支架组织瓣膜获得 FDA 批准，以改善主动脉瓣或二尖瓣疾病患者的治疗选择。透过这款新设备，雅培扩展了其 Epic 手术瓣膜平台。 2021 年 8 月，CORCYM 在现实环境中招募了第一位患者进行二尖瓣、主动脉和三尖瓣上市后研究，即 MANTRA。义大利莱切市医院进行了首次植入，并采用了碳酸氢盐主动脉机械瓣膜。 2021 年 8 月，第一个印度製造的 3D 列印心臟瓣膜在钦奈开发出来。新的心臟瓣膜是使用3D列印机开发的，可以克服人工心臟瓣膜的相关问题。因此，技术进步正在引领亚太结构心臟市场成长的新成长趋势。

亚太结构心臟市场概况

亚太结构心臟市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。该地区在全球结构心臟市场中占有重要的市场份额。由于老年人口大幅增长、心血管疾病日益严重以及该地区市场参与者推出创新产品等因素，预计亚太地区结构性心臟市场将在预测期内显着增长。

亚太地区结构心臟市场收入及 2028 年预测（百万美元）

亚太地区结构心臟市场细分

亚太地区结构心臟市场分为产品、程序、最终用户和国家。

根据产品，亚太结构心臟市场分为封堵器、瓣环成形术环、心臟瓣膜球囊等。 2022 年，封堵器细分市场占据亚太结构心臟市场的最大份额。

依手术方式，亚太结构性心臟市场分为心臟瓣膜狭窄、心臟瓣膜逆流和左心耳封堵术。 2022 年，心臟瓣膜狭窄细分市场在亚太结构性心臟市场中占据最大份额。

根据最终用户，亚太地区结构心臟市场分为医院、门诊手术中心等。 2022年，医院细分市场在亚太结构心臟市场中占据最大份额。

依国家/地区划分，亚太地区结构心臟市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022年，中国主导亚太心臟结构市场。

雅培实验室、美敦力公司、波士顿科学公司、Artivion Inc、Edwards Lifesciences Corp 和乐普医疗科技北京有限公司是亚太地区结构心臟市场的一些领先公司。

目录

第 1 章：简介

  • 研究范围
  • Insight Partners 研究报告指南
  • 市场区隔
    • 亚太结构心臟市场 - 按产品
    • 亚太结构心臟市场 - 按程序
    • 亚太结构心臟市场 - 按最终用户划分
    • 亚太地区结构心臟市场 - 按国家/地区

第 2 章：亚太地区结构心臟市场 - 要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区心臟结构市场 - 市场格局

  • 概述
  • PEST分析
    • 亚太地区 PEST 分析
  • 专家意见

第 5 章：亚太地区结构心臟市场 - 主要市场动态

  • 市场驱动因素
    • 创新结构性心臟服务的可用性
    • 心血管疾病病例和培训计画数量不断增加
  • 主要市场限制
    • 程序成本高
    • 关于结构心臟装置的严格规定
  • 主要市场机会
    • 人工智慧在结构性心臟的应用越来越广泛
  • 未来的趋势
    • 结构性心臟器械领域的技术进步
  • 影响分析

第 6 章：结构心臟市场 - 亚太地区分析

  • 亚太地区结构心臟市场收入预测与分析

第 7 章：亚太地区结构心臟市场 - 收入和 2028 年预测 - 按产品

  • 概述
  • 2021 年及 2028 年亚太地区结构心臟市场收入份额（按产品）（%）
  • 封堵器
  • 瓣环成形术环
  • 心臟瓣膜气球
  • 其他的

第 8 章：亚太地区结构心臟市场 - 2028 年收入和预测 - 按程序

  • 概述
  • 亚太地区结构心臟市场收入份额，按程序 2021 年和 2028 年 (%)
  • 心臟瓣膜狭窄
  • 心臟瓣膜逆流
  • 左心耳封堵术

第 9 章：亚太地区结构心臟市场 - 收入和 2028 年预测 - 按最终用户

  • 概述
  • 2021 年及 2028 年亚太地区结构心臟市场收入份额（按最终用户划分）（%）
  • 医院
  • 门诊手术中心
  • 心臟中心

第 10 章：亚太地区结构心臟市场 - 收入和 2028 年预测 - 国家分析

  • 亚太地区：亚太心臟结构市场
    • 概述
    • 亚太地区：亚太地区心臟结构市场，依国家划分，2021 年和 2028 年 (%)

第 11 章：亚太结构心臟市场 - 产业格局

  • 概述
  • 成长策略
    • 概述

第 12 章：公司简介

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp
  • Artivion Inc
  • Edwards Lifesciences Corp
  • Micro Interventional Devices Inc

第 13 章：附录

  • 关于洞察合作伙伴
  • 专业术语
Product Code: BMIRE00028939

The Asia Pacific structural heart market is expected to grow from US$ 2,649.67 million in 2022 to US$ 4,374.55 million by 2028. It is estimated to grow at a CAGR of 8.7% from 2022 to 2028.

Technological Advancements in the Field of Structural Heart Devices Fuel Asia Pacific Structural Heart Market

Transcatheter procedures lead to improvements in patients' heart conditions in shorter a period compared to surgical intervention. In addition, minimally invasive procedures have reduced surgical and cardiopulmonary risks, which results in increased patient satisfaction. TAVR has gathered more attention due to its ability to offer a reasonable option for the treatment of degenerative aortic stenosis. In 2017, the Edwards Lifesciences's Edwards Sapien valve was under the studies in the PARTNER trial. The valve has been made from a bovine pericardial tissue valve, and it is sutured on a cobalt-chromium stent scaffold. The stent allows the maximum possible folding of the valve, which allows to maintain the structural and radial support once it is expanded. Moreover, the recent developments in structural heart devices focus on indications, and results of left atrial appendage (LAA) and patent foramen ovale (PFO) closure to prevent cardioembolic stroke. A few of the technological advancements by the players in the Asia Pacific Structural Heart Market are mentioned. In February 2023, Medtronic announced the relaunch of its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired RVOT. Evolut FX added new features to the existing Evolut platform to enhance ease of use and predictable valve deployment for physicians. In May 2022, Philips launched EchoNavigator 4.0, the new release of its image-guided therapy solution, for the treatment of structural heart disease. EchoNavigator 4.0 provides the users of Philips' EPIQ CVXi interventional cardiology ultrasound system a control of live fusion-imaging on the company's Image Guided Therapy System called "Azurion - platform." In September 2021, Abbott received FDA approval for its Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. With this new device, Abbott expanded its Epic surgical valve platform. In August 2021, CORCYM enrolled the first patient in the Mitral, Aortic, and Tricuspid Post-Market Study in a Real-World Setting, i.e., MANTRA. The first implantation was performed at Citta di Lecce Hospital in Italy with a Bicarbon aortic mechanical valve. In August 2021, the first Made in India 3D printed heart valve was developed in Chennai. The new heart valves were developed using 3D printers, which could overcome the problems related to artificial heart valves. Therefore, technological advancements are leading to new growth trends in the Asia Pacific Structural Heart Market growth.

Asia Pacific Structural Heart Market Overview

The Asia Pacific structural heart market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The region holds a significant market share in the global structural heart market. The Asia Pacific structural heart market is expected to witness significant growth during the forecast period due to factors such as the significant growth in elderly population, growing cardiovascular diseases, and launch of innovative products by market players in the region.

Asia Pacific Structural Heart Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Structural Heart Market Segmentation

The Asia Pacific structural heart market is segmented into product, procedure, end user, and country.

Based on product, the Asia Pacific structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the Asia Pacific structural heart market in 2022.

Based on procedure, the Asia Pacific structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the Asia Pacific structural heart market in 2022.

Based on end user, the Asia Pacific structural heart market is segmented into hospitals, ambulatory surgical centres, and others. The hospitals segment held the largest share of the Asia Pacific structural heart market in 2022.

Based on country, the Asia Pacific structural heart market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific structural heart market in 2022.

Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, Edwards Lifesciences Corp, and Lepu Medical Technology Beijing Co Ltd are some of the leading companies operating in the Asia Pacific structural heart market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific structural heart market.
  • Highlights key business priorities to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific structural heart market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Structural Heart Market - by Product
    • 1.3.2 Asia Pacific Structural Heart Market - by Procedure
    • 1.3.3 Asia Pacific Structural Heart Market - by End User
    • 1.3.4 Asia Pacific Structural Heart Market - by Country

2. Asia Pacific Structural Heart Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Structural Heart Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Asia Pacific PEST Analysis
  • 4.3 Expert's Opinion

5. Asia Pacific Structural Heart Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Availability of Innovative Structural Heart Services
    • 5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost of Procedures
    • 5.2.2 Stringent Regulations Regarding Structure Heart Devices
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing Use of Artificial Intelligence in Structural Heart
  • 5.4 Future Trends
    • 5.4.1 Technological Advancements in the Field of Structural Heart Devices
  • 5.5 Impact analysis

6. Structural Heart Market -Asia Pacific Analysis

  • 6.1 Asia Pacific Structural Heart Market Revenue Forecast and Analysis

7. Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 - by Product

  • 7.1 Overview
  • 7.2 Asia Pacific Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
  • 7.3 Occluders
    • 7.3.1 Overview
    • 7.3.2 Occluders: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Annuloplasty Rings
    • 7.4.1 Overview
    • 7.4.2 Annuloplasty Rings: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Heart Valve Balloons
    • 7.5.1 Overview
    • 7.5.2 Heart Valve Balloons: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 - by Procedure

  • 8.1 Overview
  • 8.2 Asia Pacific Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
  • 8.3 Heart Valve Stenosis
    • 8.3.1 Overview
    • 8.3.2 Heart Valve Stenosis: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Heart Valve Regurgitation
    • 8.4.1 Overview
    • 8.4.2 Heart Valve Regurgitation: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Left Atrial Appendage Closure
    • 8.5.1 Overview
    • 8.5.2 Left Atrial Appendage Closure: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Ambulatory Surgical Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgical Centers: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Cardiac Centers
    • 9.5.1 Overview
    • 9.5.2 Cardiac Centers: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 -Country Analysis

  • 10.1 Asia Pacific: Asia Pacific Structural Heart Market
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific: Asia Pacific Structural Heart Market, by Country, 2021 & 2028 (%)
      • 10.1.2.1 China: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.3 China: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.1.4 China: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.1.4.1 China: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.1.4.2 China: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.1.5 China: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.2 Japan: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.3 Japan: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.2.4 Japan: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.2.4.1 Japan: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.2.4.2 Japan: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.2.5 Japan: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.3 India: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.3 India: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.3.4 India: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.3.4.1 India: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.3.4.2 India: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.3.5 India: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.4 Australia: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Australia: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.4.3 Australia: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.4.4 Australia: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.4.4.1 Australia: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.4.4.2 Australia: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.4.5 Australia: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.5 South Korea: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 South Korea: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.5.3 South Korea: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.5.4 South Korea: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.5.4.1 South Korea: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.5.4.2 South Korea: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.5.5 South Korea: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.6 Rest of Asia Pacific: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia Pacific: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.6.3 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.6.4 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.6.4.1 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.6.4.2 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.6.5 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)

11. Asia Pacific Structural Heart Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Boston Scientific Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Artivion Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Edwards Lifesciences Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Micro Interventional Devices Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. China Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. China Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. China Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. China Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. China Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Japan Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Japan Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Japan Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Japan Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Japan Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. India Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. India Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. India Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. India Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. India Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Australia Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Australia Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Australia Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Australia Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Australia Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. South Korea Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. South Korea Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. South Korea Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. South Korea Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. South Korea Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Rest of Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Rest of Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Rest of Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Rest of Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Rest of Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Recent Organic Growth Strategies in Asia Pacific Structural Heart Market
  • Table 32. Glossary of Terms

List Of Figures

  • Figure 1. Asia Pacific Structural Heart Market Segmentation
  • Figure 2. Asia Pacific Structural Heart Market, by Country
  • Figure 3. Asia Pacific Structural Heart Market Overview
  • Figure 4. Occluders Segment Held Largest Share of Product Segment in Asia Pacific Structural Heart Market
  • Figure 5. Asia Pacific: PEST Analysis
  • Figure 6. Asia Pacific Structural Heart Market Experts' Opinion
  • Figure 7. Asia Pacific Structural Heart Market: Impact Analysis of Drivers and Restraints
  • Figure 8. Asia Pacific Structural Heart Market - Revenue Forecast and Analysis - 2019-2028
  • Figure 9. Asia Pacific Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
  • Figure 10. Occluders: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 11. Annuloplasty Rings: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Heart Valve Balloons: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Others: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Asia Pacific Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
  • Figure 15. Heart Valve Stenosis: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Heart Valve Regurgitation: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Left Atrial Appendage Closure: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Asia Pacific Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
  • Figure 19. Hospitals: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Ambulatory Surgical Centers: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Cardiac Centers: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Asia Pacific Structural Heart Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 23. Asia Pacific: Asia Pacific Structural Heart Market, by Country, 2021 & 2028 (%)
  • Figure 24. China: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Japan: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. India: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Australia: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. South Korea: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Rest of Asia Pacific: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)